Fig. 1From: Evaluation of thiamine as adjunctive therapy in COVID-19 critically ill patients: a two-center propensity score matched studya Overall survival plot during the hospital stay comparing patients who received thiamine (88 patients) as adjunctive therapy versus the control group (650 patients)—before PS matching. b Overall survival plot during the hospital stay comparing patients who received thiamine (83 patients) as adjunctive therapy versus the control group (83 patients)—after PS matchingBack to article page